AIMS Medical Science, 2015, 2(1): 15-25. doi: 10.3934/medsci.2015.1.15

Review Special Issues

Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Biofluid-based microRNA Biomarkers for Parkinsons Disease: an Overview and Update

Sapana Shinde, Sayantoni Mukhopadhyay, Ghada Mohsen, Sok Kean Khoo

Department of Cell and Molecular Biology, Grand Valley State University, Grand Rapids, MI 49503, USA

Received date: , Accepted date: , Published date:

Special Issues: Biofluid Biomarkers for Parkinson’s Disease

Abstract    Full Text(HTML)    Figure/Table    Related pages

Parkinson's disease (PD) is a highly debilitating motor disorder and is the second most common neurodegenerative disease after Alzheimer's disease. Its current method of diagnosis mainly relies on subjective clinical rating scales in the presence of clinical motor features. Early detection of PD is a known challenge as neuronal cell death may range from 50% to 80% when a patient is first diagnosed with PD. Therefore, there is an urgent need to identify and develop biomarkers for early detection of this progressive disease. This mini review focuses on the recent developments of biofluid-based microRNAs (miRNAs) as molecular biomarkers for PD. A comprehensive list of miRNA biomarkers found in blood, plasma, serum, and cerebral spinal fluid is presented. Challenges and future perspectives of using these PD-related molecular biomarkers in a “real-world” clinical setting are also discussed.
  Figure/Table
  Supplementary
  Article Metrics
Download full text in PDF

Export Citation

Article outline

Copyright © AIMS Press All Rights Reserved